Voyager Therapeutics, Inc. — Form D
Voyager Therapeutics, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-23. $60.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-04-23
- Form: D
- Accession: 0001640266-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $60.0M
- Investors: 10
- Date of first sale: 2015-04-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-238528
Issuer
- Name: Voyager Therapeutics, Inc.
- CIK: 0001640266
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Phone: 857-259-5340
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| James Geraghty | Director | Cambridge, MA |
| Mark Levin | Director | New York, NY |
| Steven Paul | Director | Boston, MA |
| Mitchell S Bloom | Executive Officer | New York, NY |
| Steven Paul | Executive Officer | Boston, MA |
| MICHAEL HIGGINS | Director | FRAMINGHAM, MA |
| James A Geraghty | Director | Lexington, MA |
| Grace A Colon | Director | Lexington, MA |
| Glenn A Pierce | Director | Lexington, MA |
| Steven A Hyman | Director | Lexington, MA |
| George A Scangos | Director | Lexington, MA |
| Peter Pfreundschuh | Executive Officer | Lexington, MA |
| Jacquelyn Fahey Sandell | Executive Officer | Lexington, MA |
| Nancy A Vitale | Director | Lexington, MA |
| Alfred Sandrock | Director | Lexington, MA |
| Alfred Sandrock | Executive Officer | Lexington, MA |
| Robin Swartz | Executive Officer | Lexington, MA |
| Jude A Onyia | Director | Lexington, MA |
| Catherine A Mackey | Director | Lexington, MA |
| Todd Carter | Executive Officer | Lexington, MA |
| Robert W Hesslein | Executive Officer | Cambridge, MA |
| Todd W Carter | Executive Officer | Cambridge, MA |
| Robin W Swartz | Executive Officer | Cambridge, MA |
| Michael W Higgins | Director | Cambridge, MA |
Other filings by this issuer (2)
More